Posterior Nasal Nerve (PNN) Rhinitis Study

Inclusion Criteria:

1. Age 22 to 75 years (inclusively)
2. Willing and able to provide informed consent
3. Willing and able to comply with the subject-specific requirements outlined in thestudy protocol
4. Seeking treatment for chronic rhinitis symptoms of at least 6 months duration andwilling to undergo an office-based procedure
5. Moderate to severe symptoms of rhinorrhea (rTNSS rating of 2 or 3 for rhinorrhea)
6. Mild to severe symptoms of nasal congestion (rTNSS rating of 1, 2 or 3 for congestion)
7. rTNSS score of greater than or equal to 6
8. Dissatisfaction with medical management, defined as usage of intranasal steroids for aminimum of 4 weeks without adequate symptom relief, as judged by the subject

Exclusion Criteria:

1. Anatomic obstructions that in the investigator's opinion limit access to the posteriornose
2. Altered anatomy of the posterior nose as a result of prior sinus or nasal surgery orinjury
3. Active nasal or sinus infection
4. Moderate to severe ocular allergic symptoms (such as eye tearing [epiphora], itching [pruritus], or redness [erythema])
5. History of significant dry eye
6. History of any of the following: nose bleeds in the past 3 months, rhinitismedicamentosa, head or neck irradiation
7. Known or suspected allergies or contraindications to the anesthetic agents and/orantibiotic medications to be used during the study procedure session
8. Known or suspected to be pregnant, or is lactating
9. Participating in another clinical research study
10. Other medical conditions which in the opinion of the investigator would predispose thesubject to poor wound healing, increased surgical risk, or poor compliance with therequirements of the study